+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Drugs Market Research Reports

Skin Cancer Diagnostics Market Forecast to 2033 - Product Thumbnail Image

Skin Cancer Diagnostics Market Forecast to 2033

  • Report
  • October 2025
  • 125 Pages
  • Global
From
Capecitabine - Global Strategic Business Report - Product Thumbnail Image

Capecitabine - Global Strategic Business Report

  • Report
  • January 2026
  • 220 Pages
  • Global
From
Actinic Keratosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Actinic Keratosis Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 354 Pages
  • Global
From
Non-Melanoma Skin Cancer - Global Strategic Business Report - Product Thumbnail Image

Non-Melanoma Skin Cancer - Global Strategic Business Report

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
Melanoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Melanoma Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 162 Pages
  • Global
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
From
Docetaxel Market Report 2025 - Product Thumbnail Image

Docetaxel Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
From
Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Unresectable Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Unresectable Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Head And Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Head And Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Cutaneous Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Cutaneous Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nonmelanoma Skin Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Nonmelanoma Skin Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically. The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer. In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more